MIXED DYSLIPIDEMIA
Clinical trials for MIXED DYSLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new MIXED DYSLIPIDEMIA trials appear
Sign up with your email to follow new studies for MIXED DYSLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to tame dangerous blood fats
Disease control OngoingThis study is testing whether a new injectable drug called BW-00112 can safely lower high levels of triglycerides and other fats in the blood of people with mixed dyslipidemia. About 145 participants, who are already taking a stable dose of a statin medication, will receive eithe…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE2 • Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Tracking the Real-World impact of a new cholesterol shot
Disease control OngoingThis study is observing how well a cholesterol-lowering injection called inclisiran works for people in their regular doctor's care. It will follow about 850 adults with high cholesterol for up to two years to see how much their 'bad' cholesterol drops and how consistently they g…
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Massive 5,000-Patient study tracks Real-Life cholesterol drug results
Knowledge-focused OngoingThis study aims to observe and learn from the real-world use of two cholesterol-lowering medications, bempedoic acid and a combination pill with ezetimibe. It will follow 5,000 adults with high cholesterol in their normal doctor's care to see how well the drugs work, their safety…
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC